Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan
View ORCID ProfileShinya Tsuzuki, Kayoko Hayakawa, Yukari Uemura, Tomohiro Shinozaki, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Hiroshi Ohtsu, Yusuke Asai, Koji Kitajima, Sho Saito, Gen Yamada, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari
doi: https://doi.org/10.1101/2021.03.09.21253183
Shinya Tsuzuki
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
2Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
Kayoko Hayakawa
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Yukari Uemura
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Tomohiro Shinozaki
5Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan
Nobuaki Matsunaga
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
Mari Terada
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Setsuko Suzuki
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Hiroshi Ohtsu
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Yusuke Asai
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
Koji Kitajima
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Sho Saito
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Gen Yamada
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Taro Shibata
6Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan
Masashi Kondo
7Center for Clinical Trial and Research Support, Fujita Health University, Aichi, Japan
Kazuo Izumi
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Masayuki Hojo
8Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
Tetsuya Mizoue
9Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Kazuhisa Yokota
10Department of Infectious Diseases, Tokyo Metropolitan Health and Medical Corporation Ebara Hospital, Tokyo, Japan
Fukumi Nakamura-Uchiyama
11Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan
Fumitake Saito
12Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan
Wataru Sugiura
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Norio Ohmagari
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Article usage
Posted September 06, 2021.
Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan
Shinya Tsuzuki, Kayoko Hayakawa, Yukari Uemura, Tomohiro Shinozaki, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Hiroshi Ohtsu, Yusuke Asai, Koji Kitajima, Sho Saito, Gen Yamada, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari
medRxiv 2021.03.09.21253183; doi: https://doi.org/10.1101/2021.03.09.21253183
Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan
Shinya Tsuzuki, Kayoko Hayakawa, Yukari Uemura, Tomohiro Shinozaki, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Hiroshi Ohtsu, Yusuke Asai, Koji Kitajima, Sho Saito, Gen Yamada, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari
medRxiv 2021.03.09.21253183; doi: https://doi.org/10.1101/2021.03.09.21253183
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)